Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.460
-0.260 (-15.12%)
At close: May 12, 2025, 4:00 PM
1.460
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 213 employees as of December 31, 2024. The number of employees increased by 5 or 2.40% compared to the previous year.
Employees
213
Change (1Y)
5
Growth (1Y)
2.40%
Revenue / Employee
$280,582
Profits / Employee
$18,347
Market Cap
113.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PLX News
- 3 days ago - Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results - PRNewsWire
- 7 days ago - Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025 - PRNewsWire
- 4 weeks ago - Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline - Seeking Alpha
- 7 weeks ago - Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025 - PRNewsWire
- 2 months ago - Protalix BioTherapeutics Says With Debt Fully Repaid, It's Well-Positioned To Execute Strategy Through 2025 And Beyond - Benzinga
- 2 months ago - Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results - PRNewsWire